PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Health, York University, Toronto, Ontario, Canada.\', \'Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.\', \'Shulich School of Law, Health Law Institute, Halifax, Nova Scotia, Canada.\', \'Department of Continuing Education, University of Oxford, Oxford, UK.\', \'Faculty of Law Toronto, University of Toronto, Toronto, Ontario, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/0020731420979824
?:hasPublicationType
?:journal
  • International journal of health services : planning, administration, evaluation
is ?:pmid of
?:pmid
?:pmid
  • 33349145
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Regulators, Pivotal Clinical Trials, and Drug Regulation in the Age of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33349145>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33349145>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all